porPrevalence and classification of drug-drug interactions in intensive care patients

被引:0
|
作者
de Almeida, Silvana Maria [1 ]
Gama, Cinthia Scatena [1 ]
Akamine, Nelson [1 ]
机构
[1] Hosp Israelita Albert Einstein, Farm Clin, Sao Paulo, SP, Brazil
来源
EINSTEIN-SAO PAULO | 2007年 / 5卷 / 04期
关键词
Drug interactions; Prescriptions; drug; Intensive care units; Medical records systems; computerized;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To identify, quantify and classify drug-drug interactions among the medications most frequently dispensed in the adult ICU of a large private tertiary care hospital over a period of 30 days. Methods: Collection of data from an electronic database on consumption and drug-drug interactions of the 50 most frequently dispensed medications. Results: During the period studied, 395 commercial brands were dispensed, representing 258 active ingredients, classified into ten large groups and 36 subgroups according to Anatomical Therapeutic Chemical criteria. Four hundred and nine drug-drug interactions were identified - 174 were severe and 235 moderate. The drug-drug interactions were classified as pharmacokinetic (30%), neurologic (22%), and cardiologic (18%), and together accounted for 70% of drug-drug interactions tracked with the Micromedex Healthcare Series (R) electronic database. The other interactions were classified as hematologic, renal, endocrine/metabolic, respiratory, muscular, gastrointestinal, hepatic, and others, comprising the remaining 30%. Conclusion: Drug-drug interactions are very common in ICU patients. They may potentially produce a significant economic and clinical impact. The use of electronic computerized systems allows a better approach for medical prescriptions making it possible to prevent and intervene in cases of harmful interactions and adverse events even before medications are dosed.
引用
收藏
页码:347 / 351
页数:5
相关论文
共 50 条
  • [21] Drug-drug interactions in Neonatal Intensive Care Units: how to overcome a challenge
    Rosen, Kai
    Wiesen, Martin H.
    Oberthuer, Andre
    Michels, Guido
    Roth, Bernd
    Fietz, Cornelia
    Mueller, Carsten
    [J]. MINERVA PEDIATRICS, 2021, 73 (02): : 188 - 197
  • [22] Identifying potential drug-drug interactions in the intensive care unit: Source matters!
    Vanham, D.
    Hantson, P.
    Wittebole, X.
    Spinewine, A.
    Sneyers, B.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1283 - 1284
  • [23] Prevalence of Potential Drug-Drug Interactions in an Intensive Care Unit at a Brazilian Hospital
    Cruciol-Souza, Joice M.
    Ferreira-Filho, Olavo F.
    Obreli-Neto, Paulo R.
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2012, 31 (10): : 1469 - 1475
  • [24] Evaluation of Drug-Drug Interactions and Side Effects in COVID-19 Patients in an Intensive Care Unit
    Taner, Neda
    Sirin, Betul
    Kizilaslan, Deniz
    Erdogan, Cem
    [J]. CYPRUS JOURNAL OF MEDICAL SCIENCES, 2022, 7 (02): : 167 - 174
  • [25] Potential drug-drug interactions when managing status epilepticus patients in intensive care: A cohort study
    Le Roux, Clementine
    Destere, Alexandre
    Hervy, Sarah
    Lloret-Linares, Celia
    Reignier, Jean
    Caillet, Pascal
    Jolliet, Pascale
    Megarbane, Bruno
    Boels, David
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (05) : 2408 - 2418
  • [26] Characterization of potential drug-drug interactions in patients hospitalized in the intensive care unit of a tertiary hospital in Bogota
    Hernandez, Marcela
    Tribino, Gabriel
    Bustamante, Carlos
    [J]. BIOMEDICA, 2018, 38 (03): : 407 - 416
  • [27] Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan
    Ismail, Mohammad
    Khan, Farmanullah
    Noor, Sidra
    Haider, Iqbal
    Inam-ul Haq
    Ali, Zahid
    Shah, Zahir
    Hassam, Mohsin
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (05) : 1052 - 1056
  • [28] Variable Linezolid Exposure in Intensive Care Unit PatientsPossible Role of Drug-Drug Interactions
    Toepper, Christoph
    Steinbach, Catherine L.
    Dorn, Christoph
    Kratzer, Alexander
    Wicha, Sebastian G.
    Schleibinger, Michael
    Liebchen, Uwe
    Kees, Frieder
    Salzberger, Bernd
    Kees, Martin G.
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (05) : 573 - 578
  • [29] Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
    Rodrigues, Aline Teotonio
    Stahlschmidt, Rebeca
    Granja, Silvia
    Pilger, Diogo
    Eiras Falcao, Antonio Luis
    Mazzola, Priscila Gava
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 53 (01)
  • [30] Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting
    Hasan, Syed Shahzad
    Lim, Kim Nai
    Anwar, Mudassir
    Sathvik, Belagodu Sridhar
    Ahmadi, Keivan
    Yuan, Adelyn Wei Li
    Kamarunnesa, Mokhtar Ahmad
    [J]. SINGAPORE MEDICAL JOURNAL, 2012, 53 (08) : 526 - 531